BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 25170305)

  • 1. Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system.
    Wang L; Di L; Noguchi CT
    Int J Biol Sci; 2014; 10(8):921-39. PubMed ID: 25170305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin, erythropoiesis and beyond.
    Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
    Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
    J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin Non-hematopoietic Tissue Response and Regulation of Metabolism During Diet Induced Obesity.
    Dey S; Lee J; Noguchi CT
    Front Pharmacol; 2021; 12():725734. PubMed ID: 34603036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and proliferative roles of erythropoietin beyond the erythroid lineage.
    Noguchi CT; Wang L; Rogers HM; Teng R; Jia Y
    Expert Rev Mol Med; 2008 Dec; 10():e36. PubMed ID: 19040789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome.
    Shimizu R; Komatsu N; Miura Y
    Exp Hematol; 1999 Feb; 27(2):229-33. PubMed ID: 10029161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin in cancer: an update.
    Tóvári J; Pirker R; Tímár J; Ostoros G; Kovács G; Döme B
    Curr Mol Med; 2008 Sep; 8(6):481-91. PubMed ID: 18781955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
    Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
    Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis.
    Forejtnikovà H; Vieillevoye M; Zermati Y; Lambert M; Pellegrino RM; Guihard S; Gaudry M; Camaschella C; Lacombe C; Roetto A; Mayeux P; Verdier F
    Blood; 2010 Dec; 116(24):5357-67. PubMed ID: 20826723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
    Liu W; Varier KM; Sample KM; Zacksenhaus E; Gajendran B; Ben-David Y
    Adv Exp Med Biol; 2020; 1223():17-30. PubMed ID: 32030683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Many Facets of Erythropoietin Physiologic and Metabolic Response.
    Suresh S; Rajvanshi PK; Noguchi CT
    Front Physiol; 2019; 10():1534. PubMed ID: 32038269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hematopoietic progenitors express erythropoietin.
    Stopka T; Zivny JH; Stopkova P; Prchal JF; Prchal JT
    Blood; 1998 May; 91(10):3766-72. PubMed ID: 9573013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retrovirus-mediated expression.
    Chida D; Miura O; Yoshimura A; Miyajima A
    Blood; 1999 Mar; 93(5):1567-78. PubMed ID: 10029585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin and Hypothalamic-Pituitary Axis.
    Dey S; Noguchi CT
    Vitam Horm; 2017; 105():101-120. PubMed ID: 28629513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.
    Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis.
    Held MA; Greenfest-Allen E; Jachimowicz E; Stoeckert CJ; Stokes MP; Wood AW; Wojchowski DM
    Exp Hematol; 2020 Apr; 84():29-44. PubMed ID: 32259549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin (Epo) and EpoR expression and 2 waves of erythropoiesis.
    Lee R; Kertesz N; Joseph SB; Jegalian A; Wu H
    Blood; 2001 Sep; 98(5):1408-15. PubMed ID: 11520789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extra-hematopoietic role of erythropoietin in diabetes mellitus.
    Choi D; Retnakaran R; Woo M
    Curr Diabetes Rev; 2011 Jul; 7(4):284-90. PubMed ID: 21644916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.